MRK vs VEEV · P/E 33, rev $16.61B vs P/E 27, rev $1.81B
Merck & Company Inc (MRK) versus Veeva Systems Inc Class A (VEEV) — a side-by-side from cached financials, not a winner call.
Merck & Company Inc (MRK) is a drug manufacturers - general company listed on NYSE. It is led by Rob Davis.
Veeva Systems Inc Class A (VEEV) is a health information services company listed on NYSE.
Latest reported MRK revenue for 2026-06-30 was $16.61B. Net income was -$1.33B. Revenue was up 2.0% from 2026-03-31 to 2026-06-30. MRK currently screens at market cap $285.12B and trailing P/E 32.5.
Latest reported VEEV revenue for 2026-07-31 was $1.81B. Net income was $534.4M. VEEV currently screens at market cap $25.15B and trailing P/E 27.5.
MRK currently screens at market cap $285.12B and trailing P/E 32.5. VEEV currently screens at market cap $25.15B and trailing P/E 27.5.
Not investment advice. Open the MRK and VEEV stock pages for the full models.
Not investment advice.